David Nierengarten
Stock Analyst at Wedbush
(4.88)
# 318
Out of 4,966 analysts
569
Total ratings
54%
Success rate
22.4%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding | Maintained: Buy | $64 | $55.41 | +15.50% | 20 | Sep 14, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Hold | $53 → $13 | $11.74 | +10.73% | 15 | Sep 9, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | $123 | $88.28 | +39.33% | 13 | Sep 9, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,150 | $984.39 | +16.82% | 61 | Sep 3, 2026 | |
| TCRX TScan Therapeutics | Downgraded: Hold | $5 → $1 | $0.3204 | +212.11% | 7 | Sep 3, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $35 | $23.30 | +50.21% | 1 | Aug 19, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Buy | $45 | $31.34 | +43.59% | 4 | Aug 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $55 → $64 | $39.40 | +62.44% | 4 | Aug 12, 2026 | |
| STTK Shattuck Labs | Reiterated: Buy | $11 | $6.20 | +77.42% | 4 | Aug 12, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $11 | $2.81 | +291.46% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $33.41 | +64.62% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.10 | +42.35% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $70.06 | +25.61% | 22 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $30 | $24.41 | +22.90% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $23.99 | +170.95% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $24.32 | +23.36% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $99 | $76.27 | +29.80% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $20 | $15.79 | +26.66% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.07 | +81.22% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $140 | $118.64 | +18.00% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $16.86 | +255.87% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $91.14 | +81.04% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.95 | +405.05% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $53.87 | +39.22% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $44.40 | -27.93% | 2 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.22 | +125.05% | 5 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.04 | +66.11% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | kr 40.50 | +70.37% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $35 | $14.30 | +144.76% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $22.30 | n/a | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $22.62 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.31 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $24.67 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $5.08 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.13 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $4 | $1.61 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $29.05 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $106.20 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $10.95 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $4.00 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $10 | $0.0004 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $36 | $3.19 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $650.57 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $13 | $8.87 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $11.39 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.22 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $3.58 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $4.08 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.11 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $36.90 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $0.706 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $129.41 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.07 | n/a | 1 | Mar 22, 2013 |
Scholar Rock Holding
Sep 14, 2026
Maintained: Buy
Price Target: $64
Current: $55.41
Upside: +15.50%
Intellia Therapeutics
Sep 9, 2026
Reiterated: Hold
Price Target: $53 → $13
Current: $11.74
Upside: +10.73%
Spyre Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $123
Current: $88.28
Upside: +39.33%
argenx SE
Sep 3, 2026
Reiterated: Buy
Price Target: $1,150
Current: $984.39
Upside: +16.82%
TScan Therapeutics
Sep 3, 2026
Downgraded: Hold
Price Target: $5 → $1
Current: $0.3204
Upside: +212.11%
Aktis Oncology
Aug 19, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $23.30
Upside: +50.21%
Zenas BioPharma
Aug 14, 2026
Reiterated: Buy
Price Target: $45
Current: $31.34
Upside: +43.59%
Hemab Therapeutics Holdings
Aug 12, 2026
Reiterated: Buy
Price Target: $55 → $64
Current: $39.40
Upside: +62.44%
Shattuck Labs
Aug 12, 2026
Reiterated: Buy
Price Target: $11
Current: $6.20
Upside: +77.42%
Perspective Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
Aug 11, 2026
Reiterated: Buy
Price Target: $55
Current: $33.41
Upside: +64.62%
Aug 11, 2026
Reiterated: Buy
Price Target: $40
Current: $28.10
Upside: +42.35%
Aug 11, 2026
Reiterated: Buy
Price Target: $88
Current: $70.06
Upside: +25.61%
Aug 6, 2026
Reiterated: Buy
Price Target: $26 → $30
Current: $24.41
Upside: +22.90%
Aug 5, 2026
Reiterated: Buy
Price Target: $65
Current: $23.99
Upside: +170.95%
Aug 5, 2026
Reiterated: Buy
Price Target: $30
Current: $24.32
Upside: +23.36%
Jul 28, 2026
Reiterated: Buy
Price Target: $72 → $99
Current: $76.27
Upside: +29.80%
Jul 24, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $15.79
Upside: +26.66%
Jul 21, 2026
Reiterated: Buy
Price Target: $11
Current: $6.07
Upside: +81.22%
Jul 6, 2026
Reiterated: Hold
Price Target: $110 → $140
Current: $118.64
Upside: +18.00%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $16.86
Upside: +255.87%
May 14, 2026
Reiterated: Buy
Price Target: $165
Current: $91.14
Upside: +81.04%
May 13, 2026
Reiterated: Buy
Price Target: $25
Current: $4.95
Upside: +405.05%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $53.87
Upside: +39.22%
Mar 17, 2026
Reiterated: Buy
Price Target: $32
Current: $44.40
Upside: -27.93%
Mar 11, 2026
Reiterated: Buy
Price Target: $23
Current: $10.22
Upside: +125.05%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $12.04
Upside: +66.11%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: kr 40.50
Upside: +70.37%
Oct 14, 2025
Reiterated: Hold
Price Target: $75 → $35
Current: $14.30
Upside: +144.76%
Jun 26, 2025
Reiterated: Hold
Price Target: $8
Current: $22.30
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $22.62
Upside: n/a
May 14, 2025
Reiterated: Hold
Price Target: $5
Current: $2.31
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $33
Current: $24.67
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $2
Current: $5.08
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.13
Upside: n/a
Jul 26, 2023
Reiterated: Hold
Price Target: $9 → $4
Current: $1.61
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $29.05
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $106.20
Upside: n/a
Jan 25, 2023
Reiterated: Buy
Price Target: $19 → $17
Current: $10.95
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $34 → $32
Current: $4.00
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $9 → $10
Current: $0.0004
Upside: n/a
Jun 18, 2019
Reiterated: Buy
Price Target: $19 → $36
Current: $3.19
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $650.57
Upside: n/a
Apr 23, 2018
Reiterated: Hold
Price Target: $55 → $13
Current: $8.87
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $11.39
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $1.22
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $3.58
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $4.08
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $1.11
Upside: n/a
May 9, 2016
Reiterated: Hold
Price Target: $4 → $3
Current: $36.90
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $0.706
Upside: n/a
Mar 31, 2014
Reiterated: Sell
Price Target: n/a
Current: $129.41
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $24.07
Upside: n/a